These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15089052)

  • 21. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
    Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
    Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The fundamental variables of the biopharmaceutics classification system (BCS): a commentary.
    van de Waterbeemd H
    Eur J Pharm Sci; 1998 Dec; 7(1):1-3. PubMed ID: 9845781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.
    Benet LZ
    J Pharm Sci; 2013 Jan; 102(1):34-42. PubMed ID: 23147500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.
    Avdeef A; Artursson P; Neuhoff S; Lazorova L; Gråsjö J; Tavelin S
    Eur J Pharm Sci; 2005 Mar; 24(4):333-49. PubMed ID: 15734300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical selectivity of the BBB microenvironment governing passive diffusion--matching with a porcine brain lipid extract artificial membrane permeability model.
    Tsinman O; Tsinman K; Sun N; Avdeef A
    Pharm Res; 2011 Feb; 28(2):337-63. PubMed ID: 20945153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
    Buckley ST; Frank KJ; Fricker G; Brandl M
    Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An improved prediction of the human in vivo intestinal permeability and BCS class of drugs using the in vitro permeability ratio obtained for rat intestine using an Ussing chamber system.
    Li H; Jin HE; Shim WS; Shim CK
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1515-22. PubMed ID: 22934579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel high/low solubility classification methods for new molecular entities.
    Dave RA; Morris ME
    Int J Pharm; 2016 Sep; 511(1):111-126. PubMed ID: 27349790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract.
    Zur M; Cohen N; Agbaria R; Dahan A
    Int J Pharm; 2015 Jul; 489(1-2):304-10. PubMed ID: 25957705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of drug permeabilities and BCS classification: three lipid-component PAMPA system method versus Caco-2 monolayers.
    Teksin ZS; Seo PR; Polli JE
    AAPS J; 2010 Jun; 12(2):238-41. PubMed ID: 20224985
    [No Abstract]   [Full Text] [Related]  

  • 34. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.
    Lindenberg M; Kopp S; Dressman JB
    Eur J Pharm Biopharm; 2004 Sep; 58(2):265-78. PubMed ID: 15296954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid throughput solubility screening method for BCS class II drugs in animal GI fluids and simulated human GI fluids using a 96-well format.
    Guo J; Elzinga PA; Hageman MJ; Herron JN
    J Pharm Sci; 2008 Apr; 97(4):1427-42. PubMed ID: 17724660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of biowaivers among Class II drugs: theoretical justification and practical examples.
    Rinaki E; Dokoumetzidis A; Valsami G; Macheras P
    Pharm Res; 2004 Sep; 21(9):1567-72. PubMed ID: 15497681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artificial membrane assays to assess permeability.
    Faller B
    Curr Drug Metab; 2008 Nov; 9(9):886-92. PubMed ID: 18991585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Permeation prediction of M100240 using the parallel artificial membrane permeability assay.
    Hwang KK; Martin NE; Jiang L; Zhu C
    J Pharm Pharm Sci; 2003; 6(3):315-20. PubMed ID: 14738711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicochemical profiling (solubility, permeability and charge state).
    Avdeef A
    Curr Top Med Chem; 2001 Sep; 1(4):277-351. PubMed ID: 11899112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biopharmaceutical classification system--experimental model of the prediction of drug bioavailability].
    Golovenko NIa; Borisiuk IIu
    Biomed Khim; 2008; 54(4):392-407. PubMed ID: 18988456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.